The primary cause of foetal illness is placental pathology. The use of diagnostic ultrasound allows for a better understanding of how the foetus may be compromised by inadequate placental function. Anaesthesia affects placental function by changing uteroplacental and umbilical placental perfusion. Regional anaesthesia may have a beneficial effect on these circulations although general anaesthesia may be adapted to produce minimal disturbance of placental circulatory dynamics. The advantages and disadvantages of particular anaesthetic techniques in the delivery of the sick foetus are discussed.
The foetus is a parasite of the mother. However, it has to survive in a potentially hostile immunological environment. This is the enigma of pregnancy.
Clinically the primary site of pathology, responsible for most common forms of foetal risk is the placenta. 1 During the nine months of pregnancy the placenta is effectively the foetal lung, gut and kidney. It is also the partition between the maternal and foetal immune systems, a filter which allows the selective transport of maternal antibodies to the foetus and a protective barrier to exclude infections and other potentially harmful agents. It also produces large quantities of specific proteins and steroids that have transport and regulatory functions but also helps modulate immune reactions.
Failure of adequate placental growth and function produces an at-risk foetus whose survival is compromised in utero. Ultimately a decision has to be made by the obstetrician as to whether the foetus has a better chance of survival in a sophisticated neonatal intensive care environment.
Anaesthesia is nearly always necessary in the delivery of these at-risk foetuses because ofthe high incidence of operative vaginal and caesarean section deliveries.
EVALUATION OF THE FOETUS IN UTERO
The assessment of the foetus in utero focuses on placental function.
Until recently, the primary measurements made were biochemical; namely, urinary and plasma oestrogens and human placental lactogen. These have now assumed a secondary importance after diagnostic ultrasound.
Diagnostic ultrasound in clinical obstetrics is used to assess foetal age, growth, congenital abnormalities and placental localisation. More sophisticated uses of ultrasound such as the assessment of foetal breathing and flow velocity waveforms in the vessels surrounding the placenta offer a broader profile of the foetus and allow the accurate time of the necessity for delivery. Foetal breathing and flow velocity waveform analysis use the continuous wave Doppler ultrasound technique.
Foetal breathing is assessed by changing patterns in the umbilical vein flow velocity waveforms. Changes in intrathoracic pressure that occur with breathing alter these waveforms. A regular rhythmical pattern indicates foetal lung maturity.
Arterial flow velocity waveforms in the vessels surrounding the placenta are used to assess arteriolar resistance in the uteroplacental and umbilical placental circulations. 2 ,3,4 The AlB ratio, i.e. the ratio of systolic flow velocity (A) and diastolic flow velocity (B) is commonly used. A reduction in this ratio with advancing gestational age occurs in signals from the umbilical artery. In pathological situations, e.g. a reduction in the placental tertiary stem villi, an increase in this ratio occurs indicating an increasing resistance to flow in the umbilical placental circulation. 5 A normal range of umbilical artery flow velocity waveforms through the second half of pregnancy has been established. Deviations outside this range indicate compromised placental function with increased foetal risk.
Directional ultrasound flow meters are able to separate positive and negative components in Doppler shift signals and thus discriminate between forward and reverse flow. With extreme pathological changes within the placenta the diastolic flow in the umbilical artery is reversed, indicating the iminent demise of the foetus in utero. This change precedes changes in foetal heart rate patterns that are pre-terminal.
The precision and accuracy of foetal umbilical artery flow velocity waveforms analysis allows a successful non-invasive method of assessing foetal survivability in utero.
ANAESTHESIA AND THE PLACENTA
Anaesthesia has its predominate effect on the placenta by changing the uteroplacental and umbilical placental perfusion. Uteroplacental blood flow is directly proportional to perfusion pressure. Jouppilla 6 reported a marked reduction in uteroplacental blood flow during the induction of general anaesthesia using a radioactive Xenon dilution technique in humans. 7 This has been corroborated in animal experiments by Cosmi and Shnider. 8 These changes are without consequence in the normal healthy foetus but promotes foetal asphyxia in the already compromised sick foetus. This consequence of general anaesthesia can be minimised by a short induction-delivery interval and the use of volatile anaesthetic agents, particularly halothane which produces uterine vasodilitation and restores uteroplacental perfusion to basal levels. 8 The umbilical placental perfusion is much more difficult to study in the human. Umbilical artery flow velocity waveforms have helped in the study of this circulation. Marx 9 and Giles lO have shown a decrease in resistance to flow in the umbilical placental circulation with epidural anaesthesia. Jouppila (1978)11 suggested in normal healthy women with a healthy pregnancy that epidural anaesthesia did not alter intervillous blood flow. However, Giles and colleagues lO have shown a decrease in uteroplacental vascular resistance with epidural anaesthesia associated with caesarean section. Veille (1988)12 showed that there was no change in the uteroplacental vascular resistance under the same circumstances. Veille's argument to support his findings was that the uteroplacenta1 circulation is maximally dilated at term and no further decrease in resistance is possible.
It is difficult to concede that adrenergic stimulation from stress at the time of delivery does not increase uteroplacental vascular resistance.
The prime benefit of epidural anaesthesia in the normal healthy parturient is to restore the uteroplacental circulation to a non-stressed basal situation.
In the toxaemia patient with a markedly compromised uteroplacental circulation, epidural anaesthesia has an enormous beneficial effect by increasing intervillous blood flow by up to 77%. 13 Giles (1987)11 also reported that fluid loading and epidural anaesthesia were associated with a concomitant decrease in the uteroplacental and umbilical placental vascular resistance. The mechanism for this change on the foetal side of the placental circulation is not understood. However, it appears to be similar to a change that occurs in the lung. Hypoxic pulmonary vascular resistance is decreased by improved ventilation to that segment of the lung. 14 Here the improvement in perfusion is prostaglandin-mediated. 15 These same prostaglandins are in abundant concentration on both sides of the placental circulation.
MANAGEMENT OF ANAESTHESIA FOR THE SICK FOETUS
Regional anaesthesia has its obvious attraction for the delivery of the sick foetus because of its likely effect in improving placental function in particular the exchange of oxygen. This potential for resuscitation can occasionally be seen with the improvement in beat-to-beat variability in the foetal heart rate with epidural anaesthesia.
If vaginal delivery is contemplated, epidural anaesthesia ought to be instituted early to protect the sick foetus from the stress oflabour. However, many of these labours are complicated by foetal distress early in their course. Therefore, many obstetricians believe that elective caesarean section is the best mode of delivery.
Here the choice of anaesthesia is far more controversial. The sick foetus is often very small because of growth retardation and malpositioned within the uterus. The mother's anterior abdominal wall muscle tone is often little changed from the nonpregnant state. The anaesthetist should appreciate that the obstetrician has some difficulty in delivering the sick foetus under these circumstances.
The lack of a distinct lower segment, the abnormal presentation of the foetus and the need for an atraumatic birth seem to favour general anaesthesia for delivery by caesarean section. General anaesthesia can provide good relaxation of the anterior abdominal wall with the use of muscle relaxants. Good relaxation of the uterus can also be achieved with the use of volatile anaesthetic agents (1. 5 MAC of halothane, ethrane, or isoflurane). The combined effect of these two general anaesthetic Anaesthesia and Intensive Care. Vo/. 18. No. 3. August. 1990 agents make the delivery less of a struggle and reduces the trauma to the foetus.
However, the mother should also be considered. Often the mother is unwell. Regional anaesthesia is preferable if the mother has hypertension. Hodgkinson (1980)16 showed the prolonged detrimental effects with the induction of general anaesthesia on mean arterial pressure (MAP) and pulmonary capillary wedge pressure (PCWP) in hypertensive parturients. Regional anaesthesia avoids this and may produce a beneficial lowering of MAP. However, care must be taken that appropriate fluid loading is used to prevent the hypotension that is associated with the high block required for caesarean section.
One of the disadvantages of regional anaesthesia is that it cannot produce uterine relaxation. Peng (1989)17 described the excellent uterine relaxation achieved by the intravenous use of nitroglycerin 500 micrograms. I have now used this agent in conjunction with epidural anaesthesia for caesarean section. It produced excellent uterine relaxation without altering maternal blood pressure.
In selecting anaesthetic agents for delivery, concerns about neonatal drug effects are far less important than preventing asphyxia and trauma to the sick foetus. This probably reflects the inefficient means that these drugs have in crossing the placenta when pathology is present.
Recently the introduction of low-dose aspirin (60-150 mg)IB has produced some dramatic results in the prophylaxis of pre-eclampsia. Since Beaufils (1985) 19 introduced aspirin Walsh (1985)20 has shown that aspirin improves umbilical placental perfusion in the pre-eclamptic patient by the inhibition of thromboxane. The prostacyclinthromboxane imbalance in the uteroplacental and umbilical placental circulations is returned to its normal equilibrium. This prevents the pathological changes that are produced when thromboxane predominates.
Aspirin therapy may pose a concern for the anaesthetist. Sufficient levels of thromboxane are required for platelet aggregation. In vitro studies suggest that platelet aggregation may be inhibited by one dose of aspirin 60 mg. However, in vivo this does not appear to be a clinical problem.
In my experience of some hundred template skin bleeding times in patients on low-dose aspirin there appears to be no prolongation of the bleeding time.
It therefore appears safe to perform regional anaesthesia in this situation. However, it would appear to be a wise precaution to perform a template skin bleeding time before doing so.
There are few emergencies in anaesthesia which can be equated with that which faces the anaesthetist, who, having induced general anaesthesia for caesarean section, is then unable to intubate the trachea. The importance of this factor in terms of maternal and fetal morbidity and mortality has been emphasised by statistics from the United Kingdom which demonstrate continuing deaths from general anaesthesia in obstetrics associated with failure to intubate the trachea. 1 ,2 It is impossible to over-emphasise the necessity for the anaesthetist to have a clear and effective plan for managing this situation.
HISTORY
Any discussion of the management of failed endotracheal intubation would be incomplete without a brief reference to some of the historical material relating to tracheal intubation.
Early descriptions of tracheal intubation come from Accepted for publication April 23, 1990 reported artificial ventilation in an animal via tracheostomy. Robert Hook later repeated Vesalius' experiments for the Royal Society of Medicine in 1667, but it was Trendelenburg 4 who was the first to perform tracheostomy on man in 1869, as part of an operation on the upper airway, to prevent aspiration of blood into the lungs. MacEwen,5 a surgeon in Glasgow, was the first to perform oral endotracheal intubation for anaesthesia in 1878. MacEwen performed this manoeuvre in an awake patient prior to the commencement of anaesthesia. MacEwen's observations reported in the British Medical Journal in July 1888 are essential reading for those with an interest in the history of anaesthesia and will also remind the contemporary anaesthetist that 'awake intubation' is an important option in the management of the 'failed intubation'.
The structure of the first endotracheal tubes used for anaesthesia are most interesting. Trendelenburg had created a funnel attachment to his tracheostomy tube through which the anaesthetic vapours were given. In 1880, O'Dwyer published papers describing a tracheal tube for use during the relief of asphyxia from laryngeal obstruction caused mainly by diphtheria. O'Dwyer's tubes which were short and were intended to bypass an
